| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 |
|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
NET LOSS | |||||||||
349,404 | 268,703 | 0 | 0 | 0 | - | - | - | - | - |
NET LOSS | |||||||||
- | - | - | - | - | - | - | - | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities | |||||||||
Interest income earned in cash and investments held in trust account | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Interest income earned in cash and investments held in Trust Account | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Change in operating assets and liabilities: | |||||||||
Decrease in prepayments | |||||||||
1,845 | 849 | -3,322 | 6,670 | 26,682 | 46,693 | 66,704 | 0 | 0 | 0 |
Increase (decrease) in accrued liabilities | |||||||||
89,746 | -7,875 | 13,119 | 2,052 | 34,375 | 115,233 | 233 | 0 | 0 | 0 |
(Decrease) increase in amount due to related party | |||||||||
0 | - | - | - | 0 | - | - | - | 0 | 0 |
Cash used in operating activities | |||||||||
-650,587 | -596,974 | -479,481 | -423,331 | -288,096 | -205,372 | -195,500 | 0 | 0 | 0 |
Cash flows from investing activities | |||||||||
Proceeds deposited in Trust Account | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash used in investing activities | |||||||||
0 | 0 | 0 | -46,000,000 | -46,000,000 | -46,000,000 | -46,000,000 | 0 | 0 | 0 |
Cash flows from financing activities | |||||||||
Proceeds from a related party | |||||||||
330,955 | 282,638 | 171,664 | -8,584 | -50,322 | 0 | 0 | 0 | 0 | - |
Proceeds from sale of ordinary shares to related party | |||||||||
- | - | - | - | - | 25,000 | 27,387 | 0 | 0 | 0 |
Proceeds from public offering, net of expenses | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Proceeds from private placements to related party | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Payment of offering costs | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Net cash provided by financing activities | |||||||||
330,955 | 282,638 | 171,664 | 46,915,571 | 46,873,833 | 46,949,155 | 46,951,542 | 0 | 0 | 0 |
NET CHANGE IN CASH | |||||||||
-319,632 | -314,336 | -307,817 | 492,240 | 585,737 | 743,783 | 756,042 | 0 | 0 | 0 |
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||||||
Unrealized (loss) gain on Trust Account | |||||||||
-147,960 | 152,760 | 201,736 | 219,085 | 277,735 | 0 | 0 | 0 | 0 | - |
Changes in ordinary shares subject to conversion | |||||||||
201,444 | 421,463 | 460,157 | 356,368 | 185,089 | 0 | 0 | 0 | 0 | - |
Expenses paid by a related party | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Proceeds of a promissory note deposited in Trust Account by a founder shareholder | |||||||||
0 | - | - | - | 0 | - | - | - | - | - |
Deferred offering costs and expenses paid by a related party | |||||||||
- | - | - | - | - | 189,929 | 284,929 | 0 | 0 | 0 |
Repurchase of ordinary shares from a founder shareholder | |||||||||
- | - | - | - | - | 1 | 1 | 0 | 0 | 0 |
Accrued underwriting compensation | |||||||||
- | - | - | - | - | - | - | - | - | 0 |